Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology

An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology: I-FILE

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The I-FILE study is a prospective multicenter, multinational observational study where the feasibility of a patient-led registry using home monitoring in patients with pulmonary fibrosis will be evaluated. The aim of the study is to gain more insights in disease behavior in patients with pulmonary fibrosis, so in future patients with progressive disease can be better identified.

Who May Be Eligible (Plain English)

Who May Qualify: Newly diagnosed patients with F-ILD according to the ATS/ERS criteria by a multidisciplinary ILD team : - MDT diagnosis ≤ 6 months before inclusion - Treatment for F-ILD ≤ than 1 month Who Should NOT Join This Trial: - Not able to speak, read or write in the native language of the country where the patient is included - Not able to comply to the study protocol, according to the judgement of the investigator and/or patient - No access to internet Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: Newly diagnosed patients with F-ILD according to the ATS/ERS criteria by a multidisciplinary ILD team : * MDT diagnosis ≤ 6 months before inclusion * Treatment for F-ILD ≤ than 1 month Exclusion Criteria: * Not able to speak, read or write in the native language of the country where the patient is included * Not able to comply to the study protocol, according to the judgement of the investigator and/or patient * No access to internet

Treatments Being Tested

OTHER

Home spirometry

* Patients will perform daily home spirometry for three months with a Bluetooth-enabled validated, CE-marked home spirometer (Spiro bank Smart, MIR, Italy). Subsequently, patients will perform weekly home spirometry for two years in total. During this period, patients will be asked to perform three measurements each week on the same day. * Hospital-based spirometry will be performed according to international guidelines. * Patients will complete patient-reported outcomes (PROMs) online in the secured application every six months.

Locations (2)

Erasmus MC
Rotterdam, South Holland, Netherlands
Erasmus MC
Rotterdam, Netherlands